InVitro International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of InVitro International generated cash of -$59,111, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore -$875,487.
Cash Flow
| 2015 | 242.23K | -87.73K | 0 |
|---|---|---|---|
| 2017 | 18.53K | -10.01K | 0 |
| 2019 | 137.72K | -87.05K | -50.61K |
| 2020 | -22.37K | -35.71K | 106.66K |
| 2021 | 31.98K | 12.07K | 101.01K |
| 2022 | 40.62K | 685.30K | -14.99K |
| 2023 | -59.11K | -816.37K | 0 |
IVRO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.23M | 521.54K | 378.93K | 330.25K | 279.49K | 414.89K | 95.58K |
Operating activities | |||||||
Net income | 1.55K | 21.27K | 95.99K | 49.89K | 70.67K | 47.83K | 232.1K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 3.37K | 3.89K | 2.71K | 3.58K | 9.81K | 17.00K | 18.67K |
Stock-based compensation expense | 11.65K | 5.25K | 9.87K | 31.64K | 0 | 0 | 0 |
| Deferred income tax benefit | 11.65K | 5.25K | 9.87K | 31.64K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -45.17K | 70.81K | 24.34K | -46.65K | -13.55K | -31.40K | -10.15K |
Inventories | -5.61K | -17.13K | 25.27K | -11.43K | -20.09K | 2.49K | -12.08K |
Accounts payable | 2.82K | 2.39K | -6.78K | -6.51K | 28.64K | 8.91K | 0 |
Cash generated by operating activities | -59.11K | 40.62K | 31.98K | -22.37K | 137.72K | 18.53K | 242.23K |
Investing activities | |||||||
Purchases Of Investments | -815.52K | -98.61K | -482.28K | -289.44K | -340.78K | -41.27K | 0 |
Investments In Property Plant And Equipment | -850 | -9.37K | -3.09K | 0 | 0 | -5.42K | -2.96K |
Acquisitions Net | 0 | -694 | -15 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -816.37K | 685.30K | 12.07K | -35.71K | -87.05K | -10.01K | -87.73K |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -14.99K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -101.01K | -106.66K | 0 | 0 | 0 |
Cash used in financing activities | 0 | -14.99K | 101.01K | 106.66K | -50.61K | 0 | 0 |
Net Change In Cash | -875.48K | 710.92K | 142.60K | 48.68K | 50.76K | 8.83K | 154.29K |
Cash at end of period | 356.98K | 1.23M | 521.54K | 378.93K | 330.25K | 423.72K | 249.87K |